A new bile acid treatment for non-alcoholic fatty liver disease
Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in nonalcoholic fatty liver disease.
Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
Reply to: CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitis
MACK-3 (Combination of HOMA, AST, CK18): A promising novel biomarker for fibrotic non-alcoholic steatohepatitis
Liver Stiffness Measurement in Non-Alcoholic Fatty Liver Disease: Two is Better than One
Prescription of Statin and Low-Density Lipoprotein Cholestrol Treatment Targets in Non-Alcoholic Fatty Liver Disease Petients
Fibroscan as a Non-Invasive Approach to Predict the Presence and Size of Varices in the Malaysian Cirrhotic Population
